Prescription drug · NDA
VePesid (Etoposide) NDC 69238-2811
Etoposide 50 mg/1 · Capsule · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69238-2811-2 | 6923828110269238281102 | 20 CAPSULE in 1 CARTON (69238-2811-2)Marketed from May 15, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- VePesid
- Generic name (nonproprietary)
- etoposide
- Active ingredients
- Etoposide — 50 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals NY LLCNDC labeler code 69238
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019557
- Marketing start
- Listing expires
- Other FDA classes
- Topoisomerase Inhibitors (Mechanism)
- Identifiers
- Product ID 69238-2811_254bddbd-10bf-4415-a1a1-bae57127edc5SPL ID 254bddbd-10bf-4415-a1a1-bae57127edc5SPL set ID 2a40f3ed-4a36-4616-af6c-b616140fd5eeRxCUI 105592, 197687UNII 6PLQ3CP4P3UPC 0369238281125
- Pharmacologic class
- Topoisomerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469238281102followed by a unit qualifier and the quantityPackage 69238-2811-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer— VePesid Capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
Excerpt only. Read the full label for complete information.
About NDC 69238-2811
- What is NDC 69238-2811?
- 69238-2811 is the product NDC for VePesid (etoposide), Etoposide 50 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- VePesid (Etoposide).
- What is the active ingredient?
- Etoposide.
- Who is the labeler?
- Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for VePesid?
- 1 other product NDC are listed under this name. See all VePesid NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other VePesid products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| VePesidetoposide | Etoposide 50 mg/1 | CapsuleOral | Onesource Specialty Pharma Limited | 83270-451 | 83270-0451-05 |
Other NDCs under NDA 019557
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| VePesidetoposide | Etoposide 50 mg/1 | CapsuleOral | Onesource Specialty Pharma Limited | 83270-451 |